Research by RCSI University of Medicine and Health Sciences has provided new insights into the mechanism behind how our circadian 24-hour body clock influences our immune response to vaccines, depending on the time of day.
The paper published in Nature Communications examined the changes taking place in the mitochondria of a key immune cell involved in the vaccine response and could help improve the design and timing of administration of future vaccines to maximise effectiveness.
It had been previously found that humans mount a greater response to certain vaccines depending on the time of day at which the vaccine is administered, however the reason behind this wasn’t clearly understood. This research has uncovered that our circadian clock is changing the shape of mitochondria within dendritic cells. The variations in the structure of mitochondria influence how well dendritic cells function throughout the day.
Research author Professor Annie Curtis, School of Pharmacy and Biomolecular Sciences at RCSI, said: “Our discovery has shed light on a crucial aspect of our body’s response to vaccination and highlights the importance of circadian rhythms in immunity. We can apply this understanding in vaccine development to ensure we receive the maximum benefits from vaccination.”
The circadian clock within dendritic cells is controlling whether mitochondria form one of two shapes either long strings, ‘networked’, or broken into small punctate pieces. It is within the networked formation that vaccination is most effective as dendritic cells have a better ability break up the vaccine into small pieces for interaction with our immune cells (T cells). Within the study, researchers used an approach to induce the networked phase which could have implications in vaccine design allowing us to optimise our immune response, irrespective of time of day.
Dr Mariana Cervantes-Silva and Dr Richard Carroll, lead authors on the paper, commented: “The importance of mitochondria beyond their common label as the ‘powerhouse of the cell’ has become increasingly clear in recent years especially within cells of the immune system. We are excited to uncover this new link to our immune system and vaccine responses.”
The majority of this study was supported through funding provided by the Science Foundation Ireland Career Development Award (CDA) programme by the Irish Research Council through a Laureate Award and an RCSI Strategic Academic Recruitment Programme (StAR) award. Further support was provided by a Conacyt grant, a SFI Investigator Award and a European Research Council Consolidator Award.